Navigation Links
Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock
Date:11/13/2009

REDWOOD CITY, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it is commencing a modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, representing approximately 17% of Maxygen's outstanding shares. The closing price of Maxygen's common stock on the Nasdaq Global Market on November 12, 2009 was $5.03.

Maxygen intends to finance the repurchases from cash on hand. At September 30, 2009, cash, cash equivalents and marketable securities totaled $203.0 million, $20.3 million of which was held by Maxygen's majority-owned subsidiary, Perseid Therapeutics LLC, and may only be used for Perseid's operations.

Under the tender offer, stockholders will have the opportunity to tender some or all of their shares at a price within a range of $5.30 to $6.10 per share. Based on the number of shares tendered and the prices specified by the tendering stockholders, Maxygen will determine the lowest per share price within the range that will enable it to buy 6,557,377 shares, or such lesser number of shares that are properly tendered. If more than 6,557,377 shares are properly tendered at or below the determined price per share, Maxygen will purchase shares tendered at the determined price per share, on a pro rated basis. Additionally, if more than 6,557,377 shares are properly tendered, the number of shares to be repurchased by Maxygen pursuant to the tender offer may, at the discretion of Maxygen, be increased by up to 2% of Maxygen's outstanding shares, or approximately 787,726 shares, without amending or extending the tender offer.

Stockholders whose shares are purchased in the offer will be paid the determined purchase price per share net in cash, without interest, promptly aft
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
2. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
3. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
4. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
7. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
8. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
9. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
10. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Holographic Optical Technologies of Augusta, ... medical imaging, is entering the world of consumer electronics ... April 20 th , 2015, the campaign will introduce ... and 22-inch displays will allow consumers to view fully ... In addition to the two displays, the company will ...
(Date:3/27/2015)... -- Victoria Vein & Surgery Clinic is the only clinic offering ... Victoria, Texas . The clinic specializes in ... treatments for a variety of medical and cosmetic conditions. High-end ... services for their patients. Since adding laser tattoo removal, Victoria ... residents get rid of their unwanted ink. ...
(Date:3/27/2015)... 27, 2015   Cypher Genomics, Inc., ... data showing that, compared to a panel of ... highly equivalent interpretations of whether certain genetic abnormalities ... in a fraction of the time. Cypher,s Mantis ... comprehensive genetic analysis in non-invasive prenatal testing (NIPT) ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3
(Date:3/29/2015)... Elfster.com, the top-rated Secret Santa generator, ... plans to publicize its gift exchange generator technology and ... as the leader in Secret Santa online gift exchanges, ... markets can see the opportunities as well. , "We ... Peter Imburg, CEO of Elster.com. "With Christmas and Valentine’s ...
(Date:3/29/2015)... Metamora, MI. (PRWEB) March 29, 2015 ... Hospital , offers comprehensive endometriosis treatment. Secondary to ... that area a closer hospital option. They continue ... and McLaren Oakland. , Endometriosis is often ... the inside of the uterus (the endometrium) grows outside ...
(Date:3/29/2015)... 2015 Telerad RxDx Multispecialty Healthcare ... NABH Accreditation on 11th January 2015. The accreditation ... Healthcare Providers) comes as a true recognition of ... Telerad RxDx., With Telerad RxDx being the first ... NABH, marks a major achievement and a significant ...
(Date:3/29/2015)... 2015 The Claudia Cohen Research ... announce today that Dr. Beth Y. Karlan has ... Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The ... Gynecologic Oncology 46th Annual Meeting on Women's Cancer in ... Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer ...
(Date:3/29/2015)... York, NY (PRWEB) March 29, 2015 ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) pending in the ... scheduled the litigation’s next Case Management Conference for ... that the meeting will address the progress of ... who allegedly experienced heart attacks, strokes and other ...
Breaking Medicine News(10 mins):Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Endometriosis 2Health News:NABH Accreditation for Telerad RxDx – Whitefield. 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3
... -- If you have a sweet tooth, you may have a ... a series of experiments that compared people,s tastes for sweets with ... were more likely to volunteer to help another person in need, ... test found that people tend to believe that people who like ...
... Gardner HealthDay Reporter , THURSDAY, Oct. 27 (HealthDay News) ... cancer by more than half in people who are predisposed to ... tablets of 300 milligrams each also cut the risk of other ... and other cancers, according to research published in the Oct. 28 ...
... lives by detecting very small tumors. However, it fails ... distinguish between benign and malignant disease. New research published ... provides a new and potentially more sensitive method using ... sensors. A team of researchers from University of ...
... Gardner HealthDay Reporter , THURSDAY, Oct. 27 (HealthDay ... rudimentary speech therapy after suffering a massive stroke at the ... spent a year-and-a-half completely isolated, unable to communicate, socialize or ... Labs in Texas, one of a handful of organizations cropping ...
... THURSDAY, Oct. 27 (HealthDay News) -- Trying to bolster ... achievement could actually make you feel depressed, according to ... U.S. college undergraduates and 2,780 high school students in ... when they assessed themselves accurately, but participants who rated ...
... why chemotherapy agents target cancer, scientists at Dana-Farber Cancer ... effective the drugs will be by determining whether a ... In a study published online by the journal ... cancer cells that are on the verge of self-destruction ...
Cached Medicine News:Health News:Will Eating Sweets Make You Sweeter? 2Health News:Daily Aspirin May Help Prevent Colon Cancer for Those at High Risk 2Health News:Daily Aspirin May Help Prevent Colon Cancer for Those at High Risk 3Health News:Speech Therapy Key to Stroke Rehab, But Many Miss Out 2Health News:Speech Therapy Key to Stroke Rehab, But Many Miss Out 3Health News:Honest Self-Assessment Better Than False Praise 2Health News:Research makes it possible to predict how cancers will respond to chemo 2Health News:Research makes it possible to predict how cancers will respond to chemo 3
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
... The microprocessor controlled, Blanketrol II ... system provides effective patient warming ... system! The Blanketrol II offers ... flow rates of any hyper-hypothermia ...
Medicine Products: